Free tool
FAERS Monitor: Voquezna Dual Pak
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215153 or its brand name (Voquezna Dual Pak, Amoxicillin, Vonoprazan Fumarate). Reports on generic versions are filed under their own applications.
Reports
24
Serious
4
17% of reports
Hospitalization
2
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea5
- drug ineffective4
- abdominal pain upper3
- diarrhoea3
- dizziness3
- dyspnoea3
- off label use3
- oropharyngeal pain3
- cough2
- decreased appetite2
- headache2
- hospitalisation2
- illness2
- influenza like illness2
- pain2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 11 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,135 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| oropharyngeal painSignal | 3 | 28.4 | 9.9 | 55 |
| influenza like illness | 2 | 21.3 | 5.6 | 21 |
| illness | 2 | 17.0 | 4.5 | 16 |
| abdominal pain upperSignal | 3 | 12.8 | 4.4 | 22 |
| hospitalisation | 2 | 11.4 | 3.0 | 10 |
| decreased appetite | 2 | 7.5 | 2.0 | 6 |
| cough | 2 | 6.3 | 1.7 | 4 |
| nauseaSignal | 5 | 5.5 | 2.5 | 15 |
| dizzinessSignal | 3 | 5.3 | 1.8 | 7 |
| dyspnoeaSignal | 3 | 4.6 | 1.6 | 5 |
| diarrhoeaSignal | 3 | 4.1 | 1.4 | 4 |
| off label use | 3 | 3.0 | 1.0 | 2 |
| pain | 2 | 2.9 | 0.8 | 1 |
| headache | 2 | 2.8 | 0.7 | 1 |
| drug ineffective | 4 | 2.7 | 1.1 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.